{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-015313","form_type":"8-K","ticker":"CRVO","cik":"0001053691","company_name":"CervoMed Inc.","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.789177+00:00","generated_at":"2026-06-14T19:14:03.903254+00:00","sec_items":["1.01","5.02","1.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Diffusion Pharmaceuticals CFO William Hornung departs; separation agreement provides $254K lump sum","bullets":["CFO William K. Hornung departed effective May 15, 2023, after serving since September 2018.","Separation benefits include lump-sum of $254,663 (9 months base salary) and pro-rated bonus of $44,014.","Vested stock options remain exercisable for 3 months post-separation.","Health insurance premium reimbursement of $25,388 provided for 12 months.","No successor CFO named; CEO Robert J. Cobuzzi Jr. remains."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-015313","json":"https://secwatch.observer/filing/0001437749-23-015313.json","markdown":"https://secwatch.observer/filing/0001437749-23-015313.md","text":"https://secwatch.observer/filing/0001437749-23-015313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923015313/0001437749-23-015313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923015313/dffn20230519_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T19:14:03.903254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a4e2c59d0","claim":"William K. Hornung departed as Chief Financial Officer at CervoMed Inc..","evidence_excerpt":"Effective as of the close of business on May 15, 2023, Mr. William K. Hornung departed Diffusion Pharmaceuticals Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923015313/0001437749-23-015313-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}